Replies to post #5784 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

I think it would have been $40 with positive results in the cancer study. Now I doubt it will go for over $25.
-Fritz

[Fred Kadiddlehopper]

As to the timing of the upgrades, I do expect a sale of the company, but I don't think there is a direct connection with the recent analyst upgrades. Do you?
I did see an article somewhere this morning that there tends to be a spate of buyouts around the time of the upcoming annual JPM investors' conference (which is this coming Monday).
(While skeptical, I hope you are right about the $40 price tag!)
Good luck!
-Fritz